Introduction. We have previously observed that rat synovial membranes incubated in medium containing cartilage interstitial fluid (CIF) responded by changes in the expression of hyaluronan synthases (HAS1 and HAS2), collagen type I, versican, aggrecan, lubricin, matrix metalloproteinases 2 and 3 (MMP2 and MMP3), tissue inhibitors of metalloproteinases (TIMP1, 2 and 3), transforming growth factor b1 (TGFb1), tumor necrosis factor (TNF), interleukin (IL) 1b and IL-6. The aim of the study was to evaluate the influence of particular cytokines found in CIF on the gene expression of extracellular matrix (ECM) proteins in synovial membrane cells. Material and methods. Synovial membranes (SMs) were removed from the knee joints of inbred, male Lewis rats and incubated with insulin-like growth factor 1 (IGF1), TGFb1, basic fibroblast growth factor (bFGF) and granulocyte-macrophage colony-stimulating factors (G-CSF and M-CSF), either individually or in the combinations TGFb1/IGF1, TGFb1/IGF1/bFGF or G-CSF/M-CSF. Next, total RNA was isolated and the studied genes' expression was evaluated by real-time PCR. Results. TGFb1/IGF1 stimulated expression of HAS1, lubricin, collagen type I, aggrecan and TGFb1, inhibited expression of MMP3 and TNF and had no effect on TIMP1 and IL-6 mRNA levels. TGFb1/IGF1/bFGF stimulated the expression of HAS1, lubricin and TGFb1 genes, inhibited the expression of TNF and had no effect of the expression of collagen 1, aggrecan, MMP3, TIMP1 and IL-6 genes. G-CSF/M-CSF stimulated the expression of aggrecan. TGFb1, bFGF, and IGF1 applied individually exerted inhibitory effect on the expression of lubricin. TGFb1 and bFGF inhibited expression of MMP3 and bFGF inhibited also the expression of aggrecan and TNF. Conclusions. The response of the studied genes represents a resultant activity of all major cell types building the synovial membrane, i.e. highly specialized synovial fibroblasts, macrophages, epithelial cells and adipocytes. The results of our study can improve understanding of synovial membrane responses to the intraarticular injections of platelet-rich plasma (PRP) used for the treatment of joint ailments, since PRP contains factors which are also present in
Introduction
Articular cartilage has the unique mechanical property of being able to withstand compressive loads.
This ability is attributed to the association between type II collagen fibrils, decorin and biglycan, which form a network that surrounds and restrains the very large, highly hydrated aggregates of the proteoglycan aggrecan [1] . Chondrocytes produce not only matrix components, but also numerous cytokines and growth factors [2, 3] . Synovial membrane is formed by four main types of cells, i.e. highly specialized synovial fibroblasts, macrophages, epitheliocytes and adipocytes. Functional and metabolic interaction between articular cartilage and synovial membrane is, www.fhc.viamedica.pl however, poorly characterized. Cells of the synovial membrane may respond to joint loading producing humoral factors such as growth factors, cytokines and enzymes which can be released into the synovial fluid [4] . Indeed, synoviocytes secrete factors inducing synthesis of metalloproteinases by chondrocytes [5] and normal synovial fluid contains proteoglycan-degrading enzymes [4] . Synovial fluid stimulates also collagen type II, glycosaminoglycan and proteoglycan synthesis in articular cartilage [6] . Hyaluronic acid and lubricin produced by synovial membrane participate in articular cartilage lubrication [7] . On the other hand, during joint loading about 10% of liquid present in cartilage is squeezed and contributes to the hydrostatic lubrication of the articular surfaces [8, 9] . Since chondrocytes produce numerous growth factors, these factors could be present in the liquid released from loaded cartilage. Thus, synovial fluid probably contains a mixture of factors produced by synovial membrane and articular cartilage cells. Van de Lest et al. [4] found that the synovial fluid collected from ponies after they had been exercised for a week contained increased level of IGF1 in comparison with that obtained after a period of box rest but it was not established whether IGF1 was produced by synovium, articular chondrocytes, or both.
We have previously harvested cartilage interstitial fluid (CIF) from cartilages of young rats and evaluated its influence on gene expression in the synovial membrane [10] . Using ELISA assays we detected in CIF the presence of seven cytokines: basic fibroblast growth factor (bFGF), insulin-like growth factor 1 (IGF1), transforming growth factor b1 (TGFb1), bone morphogenetic protein 7 (BMP7), macrophage colony-stimulating factor (M-CSF), granulocyte colony-stimulating factor (G-CSF) and leukemia inhibitory factor (LIF). CIF stimulated expression of hyaluronan synthases 1 and 2 (HAS1 and HAS2), collagen type I, versican, aggrecan, lubricin, matrix metalloproteinases 2 and 3 (MMP2 and MMP3), tissue inhibitors of metalloproteinases 1, 2 and 3 (TIMP1, TIMP2 and TIMP3), transforming growth factor b1 (TGFb1) and interleukin 6 (IL-6), while the expression of tumor necrosis factor (TNF) and interleukin 1b (IL-1b) was inhibited. Composition of all factors detected in CIF (CIF-like cocktail) stimulated expression of HAS1, lubricin, collagen type I, aggrecan, TIMP1 and TGFb1, but contrary to CIF, did not change the expression of MMP-3, IL-6 and TNF [10] . In the present work we analyzed the effects of particular growth factors detected in CIF, either used alone or in combination, to establish which of them exert the strongest effect on the gene expression of ECM proteins in cultured synovial membrane cells.
Material and methods
Animals. Synovial membranes (SMs) were removed from the knee joints of specific pathogen-free, inbred, male Lewis rats (n = 42; 3 month-old) purchased from the Animal Unit of the Mossakowski Medical Research Centre at the Polish Academy of Sciences (Warsaw, Poland). The present study and the methods were approved by the Animal Ethics Committee of the Medical University of Warsaw (Warsaw, Poland).
Preparation of rat synovial membranes. Rats were euthanized by inhalation of halothane. After opening the knee joint cavity, the SM was excised together with the patella, the patellar ligament and the joint capsule. The SM with the infrapatellar fat pad was then separated from the other tissues according to the method described previously [11] .
Incubation of synovial membrane. As a standard procedure dissected SMs were incubated in flat-bottomed 24-well plates (Corning, Inc., Corning, NY, USA) in humidified atmosphere of 5% CO 2 in air at 37°C with constant, slow motion (300 rpm/min), for 4 h. The choice of the incubation time was based on various data from the literature and our own experience [12] . We expected that it will be sufficient for stimulation of most of the studied genes. Furthermore, the 4 hour-long incubation time was dictated by the fear that the response of the synovial membrane kept in vitro for longer times may depend not only on the stimulant used but also be influenced by factors released from synovial membrane cells or adjustment of the tissue to incubation conditions, i.e. to differences in oxygen tension in the joint and incubator. The SM from one knee joint served as the control to the SM from the opposite knee. The control SMs were cultured in RPMI (Gibco-BRL, Paisley, UK) with 0.1% bovine albumin (Sigma-Aldrich Chemie, Steinheim, Germany) and 1% Antibiotic/Antimycotic Solution (Sigma-Aldrich). Experimental SMs were incubated in the medium enriched with recombinant cytokines in concentration found in CIF. The following cytokines: bFGF (2.5 ng/mL) G-CSF (25 pg/ mL), M-CSF (60 pg/mL), (PromoKine, PromoCell GmbH, Heidelberg, Germany), TGFb1 (0.5 ng/mL) (Sigma-Aldrich) and IGF1 (2 ng/mL) (R & D Systems, Minneapolis, MN, USA) were used in following combinations: TGFb1/IGF1, TGFb1/IGF1/bFGF or G-CSF/M-CSF. After incubation the total RNA from synovial membrane cells was isolated and the expression of genes encoding HAS1, lubricin, collagen type I, aggrecan, versican, MMP3, TIMP1, IL-1b, IL-6, TNF and TGFb1 was examined.
Total synovial membrane RNA isolation. RNA was isolated with NucleoSpin ® RNA II kit (Macherey-Nagel, Duren, Germany), according to manufacturer's protocol. The quantity and quality of the isolated total RNA was evaluated spectro - [13] . A p-value < 0.05 was considered to indicate a statistically significant difference.
Results
Data presented in Figure 1 document that TGFb1/ /IGF1 stimulated expression of HAS1, lubricin, collagen type I, aggrecan. TGFb1 inhibited the expression of MMP3 and TNF and had no effects on TIMP1 and IL-6 expression. TGFb1/IGF1/bFGF stimulated the expression of HAS1, lubricin and TGFb1 and inhibited the expression of TNF. The combination of the latter three growth factors had no effect on the expression of collagen type I, aggrecan, MMP3, TIMP1 and IL-6. G-CSF/M-CSF, which due to their low concentration in CIF were used jointly, stimulated only the expression of aggrecan (Figure 1) .
TGFb1, bFGF, and IGF1 applied individually exerted inhibitory effect on the expression of lubricin. Values are expressed as the means ± SE; n = 6 in each group. Relative expression was calculated against the reference gene, GAPDH. Analysis was conducted as a relative quantification study, using control synovial membrane gene expression as a calibrator (value 1). Statistically significant differences in the expression of particular genes in relation to control synovial membranes, according to the Wilcoxon matched-pair test at p < 0.05 are marked with asterisks. Abbreviations: TNF -tumor necrosis factor; IL-6 -interleukin-6; TGFb1 -transforming growth factor b1; IGF1 -insulin-like growth factor 1; bFGF -basic fibroblast growth factor. 
Discussion
Stimulation of gene expression under influence of particular growth factors may depend on the reactivity of particular cell types present in the synovial membrane [12] . Thus, the response of the studied genes may represent a summary of activity of several cell types. A precise comparison of gene expression in the rat synovial membrane with data for particular cell types presented by other authors is difficult due to the difference in the origin of the cells, their various modifications in culture, the differences in the period of observation and the dosage of the stimulating agents. With these limitations in mind, we have nevertheless attempted some comparisons to present our data in the more general context.
Hyaluronan synthases (HASs) are expressed by human fibroblast-like synoviocytes [14] and their expression is stimulated by TGFb1 [15] . TGFb1 stimulated also hyaluronan synthesis in rat synovial membrane [16] . On the other hand, TGFb1 decreased the production of hyaluronan in mice epiphyseal growth plate but this production is stimulated by IGF1 [17] . In our present work the expression of HAS1 was not stimulated by TGFb or IGF1 acting alone, but both factors applied together exerted distinct stimulatory effect suggestive of certain synergism which, as far as we could establish, has not been observed previously.
Lubricin is produced by fibroblast-like synoviocytes and chondrocytes [7, 18] . In the previous studies TGF-b1 stimulated secretory rate of lubricin by fibroblast-like synoviocytes [19] and accumulation of lubricin in superficial zone chondrocytes and synoviocytes [20] . The discrepancies with the results of our study in which TGFb1, bFGF and IGF1 applied individually inhibited expression of lubricin while the effects of composition of TGFb1/IGF1 or TGFb1/ /bFGF/IGF1 were opposite may be probably explained by the fact that we have worked with the synovial membrane as a whole organ in which various secretory pathways could be activated.
Collagen type I within synovial membrane is produced by synovial fibroblasts [21] . Both IGF1 [22] and TGFb1 [23] enhance collagen type I gene expression in different cell types such as smooth muscle cells [22] or fibroblasts, and Ito cells [23] . In our experiments TGFb1, bFGF and IGF1 used individually did not affect its expression but stimulation occurred only when both TGFb1 and IGF1 were added to the culture medium. It may be assumed that the exposition of synovial cells to individual factors that lasted 4 hours was too short to activate transcription, but their synergic action was effective. On the other hand, stimulatory effect of TGFb1/IGF1 was inhibited by the addition of bFGF. Inhibition of IGF1 anabolic action by bFGF was also observed in articular chondrocytes by dimethylmethylene blue (DMMB) assay for proteoglycan production and DNA assay for measurements of cell numbers [24] .
Aggrecan within joint tissues is produced by chondrocytes [25] and fibroblast-like synoviocytes [26] . Although IGF1 is thought to be the major stimulator of aggrecan synthesis by articular cartilage cells [27] we did not demonstrate this effect of IGF1 used at the concentration observed in cartilage interstitial fluid [10] . IGF1 and TGFb1 used together stimulated aggrecan expression. Similar synergistic action of both agents in increasing the expression of aggrecan mRNA was also observed in rat [28] and human [29] articular chondrocytes. bFGF inhibited expression of aggrecan, similarly as in earlier reports [30] . When bFGF was applied together with TGFb1 and IGF1 the expression of aggrecan mRNA was at the level of control value. This observation is in accord with The mRNA levels of cytokines and extracellular matrix proteins in rat synovial membrane was measured by real-time PCR after incubation for 4 h with TGFb1, bFGF or IGF1. Relative gene expression was calculated against the expression of the reference gene, GAPDH.
Analysis was conducted as a relative quantification study, using control synovial membrane genes' expression as a calibrator (value 1). Values are expressed as the means ± SE. *Statistically significant difference in the expression of a particular gene in relation to control, Wilcoxon matched-pair test, p < 0.05 (n = 6 in each group). Abbreviations: bFGF -basic fibroblast growth factor; HAS1 -hyaluronan synthase 1; IGF1 -insulin-like growth factor 1; IL-6 -interleukin-6; MMP3 -matrix metalloproteinase 3; TIMP1 -tissue inhibitor of metalloproteinase 1; TGFb1 -transforming growth factor b1; TNF -tumor necrosis factor. [24] who found that the anabolic activity of IGF1 was significantly inhibited by bFGF. In our work, the strongest expression of aggrecan's mRNA occurred after the exposition of synovial cells to G-CSF/M-CSF. This novel observation extends the findings on rat chondrocytes which demonstrated stimulation of aggrecan synthesis by GM-CSF [31] and M-CSF [32] . It has to be noted that GM-CSF and G-CSF being produced by synovial fibroblasts [33] may stimulate aggrecan production in an autocrine or paracrine manner. MMP3 was shown to be produced in synovial membrane by fibroblast-like synoviocytes [34] , adipocytes [35] , endothelial cells [36] and macrophages [37] . In the present study the expression of MMP3 mRNA was inhibited by TGFb1 and bFGF acting alone and TGFb1/IGF1 acting jointly while the combination of TGFb1/IGF1/bFGF had no effect. It is unexpected result, suggesting that IGF1 does not interfere with the action of TGFb1 but inhibits action of TGFb/ /bFGF. Similarly as in this work, TGFb1 inhibited also MMP3 expression in synovial membrane after longer exposition lasting 12 hours [12] . Contrary to our result, bFGF induced expression of MMP3 in periodontal ligament (PDL) cells [38] .
Growth factors and expression of ECM proteins in synovial cells
TIMP1 is expressed in macrophages and monocytes [39] , fibroblast-like synoviocytes [40] , endothelial cells [36] and adipocytes [41] . TGFb1, in concentration 5 ng/mL, stimulated TIMP1 expression in human synovial lining cells isolated from synovial membrane [40] . In our experiments the TIMP1 expression was not changed by any of the studied factors, neither used individually or in combination, probably due to the too low concentration of the cytokines. Moreover, contrary to the other authors, who have studied the isolated populations of synovial lining cells, we worked with the synovium as a whole organ composed of several types of cells.
TNF is produced by various cell types including macrophages [42] and adipose cells [43] . We showed that TNF expression was inhibited by bFGF, and combination of growth factors TGFb1/IGF1 and TGFb1/IGF1/bFGF. Although in this study TGFb1 used individually at 2 ng/mL had no effect on the TNF mRNA level the concentration used was probably too low since in our previous work, when synovial membrane was incubated at 10 ng/mL TGFb1 for 12 h, the expression of TNF mRNA was enhanced [12] .
IL-6 can be produced by four main cell types of the synovial membrane [21, 42, 44, 45] . In our study none of the factors used, either individually or in combination, changed the expression of the IL-6 gene. Contrary to that, in our previous study, when synovial membrane was incubated for 12 h at 10 ng/mL of TGFb1, IL-6 gene expression was enhanced [12] . TGF-b1 is expressed by the fibroblast-like synoviocytes, endothelial cells [44] , adipocytes [43] and macrophages [46] and can induce its own gene expression in fibroblasts [47] , and other cell types [48] . In our study TGFb1, bFGF or IGF1 used individually did not significantly change TGFb1 expression, but it was raised by TGFb1/IGF1 and TGFb1/IGF1/bFGF. In our previous work TGFb1 used alone, stimulated its own expression, but the incubation lasted longer and the dose was higher [12] .
The response of the studied genes may represent a resultant activity of all major cell types building the synovial membrane, i.e. highly specialized synovial fibroblasts, macrophages, epithelial cells and adipocytes. Synovial membrane within joint cavity may be affected by several agents released by its cells and by articular cartilage.
Studies on the reaction of the synovial membrane as a functional unit to growth factors gain additional perspective since the introduction of intraarticular platelet-rich plasma (PRP) administration as a stimulant for chondrogenesis [49] . Growth factors released from platelets may evoke various, and as yet difficult to predict, reactions of the synovial membrane cells. PRP contains i.a. TGFb1, IGF1 and bFGF, the same factors which are present in CIF; thus results of the present work could probably be also useful for the characterization of synovial membrane response to PRP.
